Effekten af ultralyd i kombination med intraartikulær corticosteroidinjektion til arthritis
Effekten af ultralyd i kombination med corticosteroid intraartikulær injektion til arthritis
This study investigates whether ultrasound therapy applied prior to intra-articular corticosteroid injection can enhance the treatment efficacy for patients with joint arthritis and assess its safety. Adult patients diagnosed with arthritis in the limbs who are indicated for corticosteroid injection are eligible, while patients with joint replacement, hip joint involvement, gout, infectious arthritis, or local cellulitis are excluded.
Ultrasound therapy is a valuable physical therapy tool for musculoskeletal diseases, producing therapeutic effects through thermal and non-thermal mechanisms. It can improve tissue extensibility, reduce joint stiffness, increase local blood flow, enhance metabolism during tissue repair, and facilitate drug absorption. This study evaluates whether applying ultrasound before intra-articular corticosteroid injection improves therapeutic outcomes in patients with arthritis, and assesses the safety of this combined intervention. Patients aged 18 or older, diagnosed with limb arthritis, and indicated for corticosteroid injection are eligible. Exclusion criteria include joint replacement, hip joint involvement, gout, infectious arthritis, or local cellulitis at the treatment site.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Kuo-Lung Lai, MD
- Telefonnummer: +886-4-2359-2525
- E-mail: kllaichiayi@yahoo.com.tw
Studiesteder
-
-
-
Taichung, Taiwan, 407219
- Rekruttering
- Taichung Veterans General Hospital
-
Kontakt:
- Kuo-Lung Lai, MD
- Telefonnummer: +886-4-2359-2525
- E-mail: kllaichiayi@yahoo.com.tw
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adults aged 18 years or older.
- Diagnosed with arthritis in the limbs.
- Inadequate response to or contraindication for oral anti-inflammatory medications.
- Assessed by a physician as requiring intra-articular corticosteroid injection.
Exclusion Criteria:
- History of joint replacement (prosthetic joint) in the affected area.
- Hip joint involvement.
- Diagnosis of gout.
- Infectious arthritis.
- Presence of cellulitis at the treatment site.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: ultralydbehandling i kombination med corticosteroid intraartikulær injektion
|
Therapeutic Ultrasound (TUS) is a non-invasive treatment widely used in physical medicine and rehabilitation for musculoskeletal conditions. Since its introduction in the mid-20th century, TUS has gained popularity in clinical practice due to its ability to penetrate tissues, target treatment areas precisely, and exhibit minimal side effects. This study aims to investigate the mechanisms of action, clinical efficacy, and safety of therapeutic ultrasound in musculoskeletal therapy. Injection of triamcinolone (3-50 mg depending on joint size) into the affected joint. Administered once per participant. |
|
Aktiv komparator: kortikosteroid intraartikulær injektion
|
Injection of triamcinolone (3-50 mg depending on joint size) into the affected joint. Administered once per participant. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Reduction in Synovial Swelling Area Assessed by Joint Ultrasound
Tidsramme: From enrollment to the end of treatment at 2 weeks
|
Synovial swelling area (pixels) assessed by joint ultrasound. A treatment response is defined as a ≥50% reduction in synovial swelling area from baseline. |
From enrollment to the end of treatment at 2 weeks
|
|
Change in Power Doppler (PD) Score of the Target Joint
Tidsramme: From enrollment to the end of treatment at 2 weeks
|
Power Doppler (PD) score (range 0-3) of the target joint assessed by joint ultrasound. A treatment response is defined as a PD score of 0 at 2 weeks post-treatment. |
From enrollment to the end of treatment at 2 weeks
|
|
Change in Pain Visual Analogue Scale (VAS)
Tidsramme: From enrollment to the end of treatment at 2 weeks
|
Pain intensity assessed using a visual analogue scale (VAS 0-10). A treatment response is defined as a ≥50% reduction in VAS score from baseline or a VAS score ≤1 at 2 weeks post-treatment. |
From enrollment to the end of treatment at 2 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Absence of Synovitis Recurrence Based on Power Doppler (PD) Score
Tidsramme: From enrollment to 3 months post-treatment
|
Absence of synovitis recurrence assessed by Power Doppler (PD) ultrasound. Recurrence is defined as any increase in PD score compared with the 2-week post-treatment assessment. |
From enrollment to 3 months post-treatment
|
|
Absence of Synovial Swelling Recurrence on Gray-Scale Ultrasound
Tidsramme: From enrollment to 3 months post-treatment
|
Absence of synovial swelling recurrence assessed by gray-scale ultrasound. Recurrence is defined as an increase in synovial swelling area of ≥20% compared with the 2-week post-treatment assessment. |
From enrollment to 3 months post-treatment
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Kuo-Lung Lai, MD, Taichung Veterans General Hospital (TaichungVGH)
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- TCVGH-1150801B
- CF25511A (Anden identifikator: TCVGH IRB)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .